| 2026-08-05 | Press release | OraSure Announces Second Quarter 2026 Financial Results |
| 2026-08-05 | Press release | Q2-26 Earnings Release |
| 2026-07-22 | Press release | OraSure to Announce Second Quarter 2026 Financial Results and Host Earnings Call on August 5th |
| 2026-07-21 | Press release | OraSure Receives Emergency Use Authorization for Second Generation Ebola Test |
| 2026-06-11 | Press release | OraSure Technologies, Inc. Announces FDA Clearance that Expands Patient‑Friendly Access to Testing for Sexually Transmit |
| 2026-05-06 | Press release | OraSure Announces First Quarter 2026 Financial Results |
| 2026-04-22 | Press release | OraSure to Announce First Quarter 2026 Financial Results and Host Earnings Call on May 6th |
| 2026-04-16 | Press release | OraSure Technologies Appoints John D. Bertrand to its Board of Directors |
| 2026-03-30 | Presentation | OSUR Investor Infographic: Myth vs Fact – March 2026 |
| 2026-03-17 | Press release | OraSure Highlights Significant Operational Progress and Value Creation Initiatives Following Letter from Altai Capital |
| 2026-02-25 | Press release | OraSure Announces Fourth Quarter 2025 Financial Results |
| 2026-02-10 | Press release | OraSure to Launch OraQuick™ HIV Self-Test in Canada |
| 2026-01-15 | Press release | OraSure Technologies Confirms Receipt of Director Nominations from Altai Capital |
| 2026-01-05 | Press release | OraSure Submits CT/NG Molecular Self-Test and Colli-Pee™ Urine Collection Device for FDA Review |
| 2025-12-17 | Press release | OraSure Technologies Issues Statement Regarding Altai Capital’s Intent to Nominate Director Candidates |
| 2025-11-18 | Presentation | OSUR Investor Presentation – Nov 2025 |
| 2025-11-17 | Press release | OraSure to Participate in Upcoming Investor Conference |
| 2025-10-28 | Press release | OraSure Technologies Appoints Steven K. Boyd to its Board of Directors |
| 2025-08-04 | Press release | OraSure Appoints Anne Messing as Chief Commercial Officer |
| 2025-07-10 | Press release | OraSure Launches Novel Blood Collection Device for Proteomic Research |
| 2025-02-25 | Press release | OraSure Reports Fourth Quarter 2024 Financial Results |
| 2024-11-06 | Press release | OraSure Reports Q3 ’24 Revenue of $39.9 Million |
| 2024-08-06 | Presentation | Q2-24 Earnings Summary |
| 2024-08-06 | Press release | OraSure Reports Q2 ’24 Revenue of $54.3 Million |
| 2024-05-08 | Press release | OraSure Reports Q1 ’24 Revenue of $54.1 Million |
| 2024-02-27 | Press release | OraSure Reports Q4 ‘23 Revenue of $75.9 Million |
| 2023-11-07 | Press release | OraSure Reports Q3 ‘23 Revenue of $89.2 Million; Core Revenue Grows 7% Year-over-Year |
| 2023-08-03 | Presentation | Q2-23 Earnings Summary |
| 2023-08-03 | Press release | OraSure Reports Q2 ‘23 Revenue of $85.4 Million; Core Revenue Grows 3% Year-over-Year |
| 2023-05-10 | Press release | OraSure Reports 1Q23 Record Revenue of $155.0 Million; Announces New Collaborations as Company Increasingly Focuses on C |
| 2023-02-14 | Press release | OraSure Reports 4Q22 Record Revenue of $123.1 Million Growing 94% Year-Over-Year; Positions for Longer-Term Growth and P |
| 2022-11-08 | Press release | OraSure Reports 3Q22 Record Revenue of $116.5 Million Growing 116% Year-Over-Year |
| 2022-08-09 | Press release | OraSure Reports 2Q22 Record Revenue of $80.2 Million Growing 39% Year-Over-Year |
| 2022-05-10 | Press release | OraSure Reports 1Q22 Record Revenue of $67.7 Million; +16% Year-Over-Year With 21% Growth in Non-COVID Revenue |
| 2022-02-23 | Press release | OraSure Technologies Reports 4Q21 Revenue of $63.6 Million; InteliSwab® Production Scales Up |
| 2021-11-03 | Press release | OraSure Technologies Reports 3Q21 Revenue of $53.9 Million, Signs Three Major U.S. Government Contracts Positioning the |
| 2021-08-03 | Press release | OraSure Technologies Reports 2Q21 Revenue of $57.6 Million Driven by Strong Rebound in Core Business |
| 2021-05-05 | Press release | OraSure Technologies, Inc. Announces First Quarter 2021 Financial Results and Provides COVID-19 Update |